A New Feature Selection Method for LogNNet and its Application for
  Diagnosis and Prognosis of COVID-19 Disease Using Routine Blood Values
  Since February-2020, the world has embarked on an intense struggle with the
COVID-19 disease, and health systems have come under a tragic pressure as the
disease turned into a pandemic. The aim of this study is to determine the most
effective routine-blood-values (RBV) in the diagnosis/prognosis of COVID-19
using new feature selection method for LogNNet reservoir neural network. First
dataset in this study consists of a total of 5296-patients with a same number
of negative and positive covid test. Second dataset consists of a total of
3899-patients with a diagnosis of COVID-19, who were treated in hospital with
severe-infected (203) and mildly-infected (3696). The most important RBVs that
affect the diagnosis of the disease from the first dataset were
mean-corpuscular-hemoglobin-concentration (MCHC), mean-corpuscular-hemoglobin
(MCH) and activated-partial-prothrombin-time (aPTT). The most effective
features in the prognosis of the disease were erythrocyte-sedimentation-rate
(ESR), neutrophil-count (NEU), C-reactive-protein (CRP). LogNNet-model achieved
an accuracy rate of A46 = 99.5% in the diagnosis of the disease with 46
features and A3 = 99.17% with only MCHC, MCH, and aPTT features. Model reached
an accuracy rate of A48 = 94.4% in determining the prognosis of the disease
with 48 features and A3 = 82.7% with only ESR, NEU, and CRP features. LogNNet
model demonstrated a very high disease diagnosis/prognosis of COVID-19
performance without knowing about the symptoms or history of the patients. The
model is suitable for devices with low resources (3-14 kB of RAM used on the
Arduino microcontroller), and is promising to create mobile health monitoring
systems in the Internet of Things. Our method will reduce the negative
pressures on the health sector and help doctors understand pathogenesis of
COVID-19 through key futures and contribute positively to the treatment
processes.
